- •Hematuria II: causes and investigation
- •Hematospermia
- •Lower urinary tract symptoms (LUTS)
- •Nocturia and nocturnal polyuria
- •Flank pain
- •Urinary incontinence in adults
- •Genital symptoms
- •Abdominal examination in urological disease
- •Digital rectal examination (DRE)
- •Lumps in the groin
- •Lumps in the scrotum
- •2 Urological investigations
- •Urine examination
- •Urine cytology
- •Radiological imaging of the urinary tract
- •Uses of plain abdominal radiography (KUB X-ray—kidneys, ureters, bladder)
- •Intravenous pyelography (IVP)
- •Other urological contrast studies
- •Computed tomography (CT) and magnetic resonance imaging (MRI)
- •Radioisotope imaging
- •Post-void residual urine volume measurement
- •3 Bladder outlet obstruction
- •Regulation of prostate growth and development of benign prostatic hyperplasia (BPH)
- •Pathophysiology and causes of bladder outlet obstruction (BOO) and BPH
- •Benign prostatic obstruction (BPO): symptoms and signs
- •Diagnostic tests in men with LUTS thought to be due to BPH
- •Why do men seek treatment for their symptoms?
- •Watchful waiting for uncomplicated BPH
- •Medical management of BPH: combination therapy
- •Medical management of BPH: alternative drug therapy
- •Minimally invasive management of BPH: surgical alternatives to TURP
- •Invasive surgical alternatives to TURP
- •TURP and open prostatectomy
- •Indications for and technique of urethral catheterization
- •Indications for and technique of suprapubic catheterization
- •Management of nocturia and nocturnal polyuria
- •High-pressure chronic retention (HPCR)
- •Bladder outlet obstruction and retention in women
- •Urethral stricture disease
- •4 Incontinence
- •Causes and pathophysiology
- •Evaluation
- •Treatment of sphincter weakness incontinence: injection therapy
- •Treatment of sphincter weakness incontinence: retropubic suspension
- •Treatment of sphincter weakness incontinence: pubovaginal slings
- •Overactive bladder: conventional treatment
- •Overactive bladder: options for failed conventional therapy
- •“Mixed” incontinence
- •Post-prostatectomy incontinence
- •Incontinence in the elderly patient
- •Urinary tract infection: microbiology
- •Lower urinary tract infection
- •Recurrent urinary tract infection
- •Urinary tract infection: treatment
- •Acute pyelonephritis
- •Pyonephrosis and perinephric abscess
- •Other forms of pyelonephritis
- •Chronic pyelonephritis
- •Septicemia and urosepsis
- •Fournier gangrene
- •Epididymitis and orchitis
- •Periurethral abscess
- •Prostatitis: presentation, evaluation, and treatment
- •Other prostate infections
- •Interstitial cystitis
- •Tuberculosis
- •Parasitic infections
- •HIV in urological surgery
- •6 Urological neoplasia
- •Pathology and molecular biology
- •Prostate cancer: epidemiology and etiology
- •Prostate cancer: incidence, prevalence, and mortality
- •Prostate cancer pathology: premalignant lesions
- •Counseling before prostate cancer screening
- •Prostate cancer: clinical presentation
- •PSA and prostate cancer
- •PSA derivatives: free-to-total ratio, density, and velocity
- •Prostate cancer: transrectal ultrasonography and biopsies
- •Prostate cancer staging
- •Prostate cancer grading
- •General principles of management of localized prostate cancer
- •Management of localized prostate cancer: watchful waiting and active surveillance
- •Management of localized prostate cancer: radical prostatectomy
- •Postoperative course after radical prostatectomy
- •Prostate cancer control with radical prostatectomy
- •Management of localized prostate cancer: radical external beam radiotherapy (EBRT)
- •Management of localized prostate cancer: brachytherapy (BT)
- •Management of localized and radiorecurrent prostate cancer: cryotherapy and HIFU
- •Management of locally advanced nonmetastatic prostate cancer (T3–4 N0M0)
- •Management of advanced prostate cancer: hormone therapy I
- •Management of advanced prostate cancer: hormone therapy II
- •Management of advanced prostate cancer: hormone therapy III
- •Management of advanced prostate cancer: androgen-independent/ castration-resistant disease
- •Palliative management of prostate cancer
- •Prostate cancer: prevention; complementary and alternative therapies
- •Bladder cancer: epidemiology and etiology
- •Bladder cancer: pathology and staging
- •Bladder cancer: presentation
- •Bladder cancer: diagnosis and staging
- •Muscle-invasive bladder cancer: surgical management of localized (pT2/3a) disease
- •Muscle-invasive bladder cancer: radical and palliative radiotherapy
- •Muscle-invasive bladder cancer: management of locally advanced and metastatic disease
- •Bladder cancer: urinary diversion after cystectomy
- •Transitional cell carcinoma (UC) of the renal pelvis and ureter
- •Radiological assessment of renal masses
- •Benign renal masses
- •Renal cell carcinoma: epidemiology and etiology
- •Renal cell carcinoma: pathology, staging, and prognosis
- •Renal cell carcinoma: presentation and investigations
- •Renal cell carcinoma: active surveillance
- •Renal cell carcinoma: surgical treatment I
- •Renal cell carcinoma: surgical treatment II
- •Renal cell carcinoma: management of metastatic disease
- •Testicular cancer: epidemiology and etiology
- •Testicular cancer: clinical presentation
- •Testicular cancer: serum markers
- •Testicular cancer: pathology and staging
- •Testicular cancer: prognostic staging system for metastatic germ cell cancer
- •Testicular cancer: management of non-seminomatous germ cell tumors (NSGCT)
- •Testicular cancer: management of seminoma, IGCN, and lymphoma
- •Penile neoplasia: benign, viral-related, and premalignant lesions
- •Penile cancer: epidemiology, risk factors, and pathology
- •Squamous cell carcinoma of the penis: clinical management
- •Carcinoma of the scrotum
- •Tumors of the testicular adnexa
- •Urethral cancer
- •Wilms tumor and neuroblastoma
- •7 Miscellaneous urological diseases of the kidney
- •Cystic renal disease: simple cysts
- •Cystic renal disease: calyceal diverticulum
- •Cystic renal disease: medullary sponge kidney (MSK)
- •Acquired renal cystic disease (ARCD)
- •Autosomal dominant (adult) polycystic kidney disease (ADPKD)
- •Ureteropelvic junction (UPJ) obstruction in adults
- •Anomalies of renal ascent and fusion: horseshoe kidney, pelvic kidney, malrotation
- •Renal duplications
- •8 Stone disease
- •Kidney stones: epidemiology
- •Kidney stones: types and predisposing factors
- •Kidney stones: mechanisms of formation
- •Evaluation of the stone former
- •Kidney stones: presentation and diagnosis
- •Kidney stone treatment options: watchful waiting
- •Stone fragmentation techniques: extracorporeal lithotripsy (ESWL)
- •Intracorporeal techniques of stone fragmentation (fragmentation within the body)
- •Kidney stone treatment: percutaneous nephrolithotomy (PCNL)
- •Kidney stones: open stone surgery
- •Kidney stones: medical therapy (dissolution therapy)
- •Ureteric stones: presentation
- •Ureteric stones: diagnostic radiological imaging
- •Ureteric stones: acute management
- •Ureteric stones: indications for intervention to relieve obstruction and/or remove the stone
- •Ureteric stone treatment
- •Treatment options for ureteric stones
- •Prevention of calcium oxalate stone formation
- •Bladder stones
- •Management of ureteric stones in pregnancy
- •Hydronephrosis
- •Management of ureteric strictures (other than UPJ obstruction)
- •Pathophysiology of urinary tract obstruction
- •Ureter innervation
- •10 Trauma to the urinary tract and other urological emergencies
- •Renal trauma: clinical and radiological assessment
- •Renal trauma: treatment
- •Ureteral injuries: mechanisms and diagnosis
- •Ureteral injuries: management
- •Bladder and urethral injuries associated with pelvic fractures
- •Bladder injuries
- •Posterior urethral injuries in males and urethral injuries in females
- •Anterior urethral injuries
- •Testicular injuries
- •Penile injuries
- •Torsion of the testis and testicular appendages
- •Paraphimosis
- •Malignant ureteral obstruction
- •Spinal cord and cauda equina compression
- •11 Infertility
- •Male reproductive physiology
- •Etiology and evaluation of male infertility
- •Lab investigation of male infertility
- •Oligospermia and azoospermia
- •Varicocele
- •Treatment options for male factor infertility
- •12 Disorders of erectile function, ejaculation, and seminal vesicles
- •Physiology of erection and ejaculation
- •Impotence: evaluation
- •Impotence: treatment
- •Retrograde ejaculation
- •Peyronie’s disease
- •Priapism
- •13 Neuropathic bladder
- •Innervation of the lower urinary tract (LUT)
- •Physiology of urine storage and micturition
- •Bladder and sphincter behavior in the patient with neurological disease
- •The neuropathic lower urinary tract: clinical consequences of storage and emptying problems
- •Bladder management techniques for the neuropathic patient
- •Catheters and sheaths and the neuropathic patient
- •Management of incontinence in the neuropathic patient
- •Management of recurrent urinary tract infections (UTIs) in the neuropathic patient
- •Management of hydronephrosis in the neuropathic patient
- •Bladder dysfunction in multiple sclerosis, in Parkinson disease, after stroke, and in other neurological disease
- •Neuromodulation in lower urinary tract dysfunction
- •14 Urological problems in pregnancy
- •Physiological and anatomical changes in the urinary tract
- •Urinary tract infection (UTI)
- •Hydronephrosis
- •15 Pediatric urology
- •Embryology: urinary tract
- •Undescended testes
- •Urinary tract infection (UTI)
- •Ectopic ureter
- •Ureterocele
- •Ureteropelvic junction (UPJ) obstruction
- •Hypospadias
- •Normal sexual differentiation
- •Abnormal sexual differentiation
- •Cystic kidney disease
- •Exstrophy
- •Epispadias
- •Posterior urethral valves
- •Non-neurogenic voiding dysfunction
- •Nocturnal enuresis
- •16 Urological surgery and equipment
- •Preparation of the patient for urological surgery
- •Antibiotic prophylaxis in urological surgery
- •Complications of surgery in general: DVT and PE
- •Fluid balance and management of shock in the surgical patient
- •Patient safety in the operating room
- •Transurethral resection (TUR) syndrome
- •Catheters and drains in urological surgery
- •Guide wires
- •JJ stents
- •Lasers in urological surgery
- •Diathermy
- •Sterilization of urological equipment
- •Telescopes and light sources in urological endoscopy
- •Consent: general principles
- •Cystoscopy
- •Transurethral resection of the prostate (TURP)
- •Transurethral resection of bladder tumor (TURBT)
- •Optical urethrotomy
- •Circumcision
- •Hydrocele and epididymal cyst removal
- •Nesbit procedure
- •Vasectomy and vasovasostomy
- •Orchiectomy
- •Urological incisions
- •JJ stent insertion
- •Nephrectomy and nephroureterectomy
- •Radical prostatectomy
- •Radical cystectomy
- •Ileal conduit
- •Percutaneous nephrolithotomy (PCNL)
- •Ureteroscopes and ureteroscopy
- •Pyeloplasty
- •Laparoscopic surgery
- •Endoscopic cystolitholapaxy and (open) cystolithotomy
- •Scrotal exploration for torsion and orchiopexy
- •17 Basic science of relevance to urological practice
- •Physiology of bladder and urethra
- •Renal anatomy: renal blood flow and renal function
- •Renal physiology: regulation of water balance
- •Renal physiology: regulation of sodium and potassium excretion
- •Renal physiology: acid–base balance
- •18 Urological eponyms
- •Index
550 CHAPTER 15 Pediatric urology
Hypospadias
Definition
Hypospadias is a congenital deformity in which the opening of the urethra (the meatus) occurs on the underside (ventral) part of the penis, anywhere from the glans to the perineum. It is often associated with a hooded foreskin and chordee (ventral curvature of the penile shaft).
It occurs in 1 in 250 live male births. There is an 8% incidence in offspring of an affected male, and a 14% risk in male siblings.
Classification
Hypospadias can be classified according to the anatomical location of the urethral meatus (Fig. 15.4).
•Anterior (or distal)—glandular, coronal, and subcoronal (~50%)
•Middle—distal penile, midshaft, and proximal penile (~30%)
•Posterior (or proximal)—penoscrotal, scrotal, and perineal (~20%)
Etiology
Hypospadias results from incomplete closure of urethral folds on the underside of the penis during embryological development. This is related to a defect in production or metabolism of fetal androgens, or the number and sensitivity of androgen receptors in the tissues.
Chordee is caused by abnormal urethral plate development, and the hooded foreskin is due to failed formation of the glandular urethra and fusion of the preputial folds (resulting in a lack of ventral foreskin but an excess of dorsal tissue).
Diagnosis
A full clinical examination will make the diagnosis. However, it is also important to seek out associated abnormalities that will need treatment (undescended testes, inguinal hernias, and hydroceles).
Patients with absent testes and severe hypospadias should undergo chromosomal and endocrine investigation to exclude intersex conditions.
Treatment
Surgery is indicated where deformity is severe, interferes with voiding, OR is predicted to interfere with sexual function. Surgery is now performed between 6 and 12 months of age. Local application of testosterone for 1 month preoperatively can help increase tissue size.
The aim of surgery is to correct penile curvature (orthoplasty), reconstruct a new urethra, and bring the new meatus to the tip of the glans using urethroplasy, glanuloplasty, and meatoplasty techniques.
Severe cases may require staged procedures. Common operations for anterior hypospadias include meatal advancement and glanuloplasty (MAGPI), meatal-based flaps (Mathieu procedure), and tubularization of the urethral plate.
Posterior defects require free grafts (buccal mucosa), on-lay grafts, and preputial transfer flaps.
HYPOSPADIAS 551
Complications
These include bleeding, infection, urethral strictures, meatal stenosis, urethrocutaneous fistula, urethral diverticulum, and failed procedures requiring reoperation.
Anterior Glanular
(Distal) Coronal Subcoronal
Distal penile
Middle Midshaft
Proximal penile
Penoscrotal
Posterior Scrotal (Proximal)
Perineal
Figure 15.4 The anatomical classification of hypospadias according to the location of the urethral meatus. This figure was published in Walsh PC, et al. Campbell’s Urology, 8th Edition, p. 2287. Copyright Elsevier 2002.
552 CHAPTER 15 Pediatric urology
Normal sexual differentiation
Sexual differentiation and gonadal development is determined by the sex chromosomes (XY male, XX female). The gonads produce hormones that influence the subsequent differentiation of internal and external genitalia (Figs. 15.5 and 15.6).
Both sexes
Gonads develop from the genital ridges (formed by cells of the mesonephros and coelomic epithelium). At 5–6 weeks, primordial germ cells migrate from the yolk sac to populate the genital ridges. Primitive sex cords are formed, which support germ cell development.
From 4 weeks, the mesonephric (Wolffian) ducts are incorporated into the genital system, when renal function is taken over by the definitive kidney. At 6 weeks, coelomic epithelium creates the paramesonephric (Müllerian) ducts, which develop laterally and are fused to the urogenital sinus at their bases.
Males
The testis-determining gene (SRY) is located on the Y chromosome and stimulates medullary sex cords in the primitive testis to differentiate into Sertoli cells, which produce Müllerian inhibiting substance (MIS) at 7–8 weeks. This triggers regression of the paramesonephric ducts, testosterone secretion from Leydig cells of the testis, and the initial phase of testicular descent.
During weeks 8–12, mesonephric ducts differentiate into epididymis, vas deferens, seminal vesicles, and ejaculatory ducts. The prostate is formed from mesenchyme (capsule) and urethral endoderm.
After week 23, the testes rapidly descend from the abdomen (via the inguinal canal during weeks 24–28) and into the scrotal sac, guided by the gubernaculum. The scrotum is created by fusion of labioscrotal folds.
Testosterone and dihydrotestosterone (DHT) androgens are responsible for masculinization. DHT is made from testosterone by 5-D-reductase enzyme in the tissues.
Development of the external genitalia occurs from week 7. Urogenital folds develop around the opening of the urogenital sinus, and labioscrotal swellings form either side. The penile shaft and glans are formed by elongation of the genital tubercle and fusion of urogenital folds.
Incomplete production or activity of DHT in the male fetus will result in incompletely virilized male genitalia.
Females
The genital ridge forms secondary sex cords (primitive sex cords degenerate) that surround the germ cells to create ovarian follicles (week 15). These undergo meiotic division to become primary oocytes, which are later activated to complete gametogenesis at puberty.
NORMAL SEXUAL DIFFERENTIATION 553
Estrogen is produced from week 8 under the influence of the aromatase enzyme. In the absence of MIS, the mesonephric ducts regress, and the paramesonephric ducts become the fallopian tubes, uterus, and upper two-thirds of the vagina. The sinovaginal sinus develops at the junction of the paramesonephric ducts and the urogenital sinus. This forms the lower third of the vagina.
The genital tubercle forms the clitoris; the urogenital folds become the labia minora; and the labioscrotal swellings form the labia majora.
Genital tubercle |
|
Urogenital fold |
Urogenital membrane |
Labioscrotal swelling |
Anal membrane |
Clitoris |
Genital |
|
tubercle |
Labia minora
Urogenital sinus
Labia majora
Labioscrotal swelling
Figure 15.5 Differentiation of external genitalia (weeks 7–16).
Mesonephros
Gonad
Mesonephric duct
Paramesonephric duct
Figure 15.6 Differentiation of the genital tract.
Glans
Penile shaft
Urethra
Scrotum
Ovary
Fallopian tube Mesonephric duct
Paramesonephric ducts